KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind ®, a leading mental health care company, is launching on August 10, 2019 Genomind Professional PGx Express™, a new, more focused report and set of ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind – a leading mental health care company – today announced that its flagship pharmacogenetic product, Genomind Professional PGx™, is now available to ...

KING OF PRUSSIA, PA--(Marketwired - December 10, 2015) - The largest audience to date will soon learn how personalized medicine for brain health is making a difference for patients. "Innovations," an ...

KING OF PRUSSIA, PA--(Marketwired - January 09, 2017) - In 2016, more Americans underwent genetic testing performed by Genomind (www.genomind.com) to help guide treatment of mental illness than in any ...

King of Prussia-based mental health company Genomind recently expanded its partnership with Acme markets, making its genetic testing service available to patients in all 37 Acme pharmacies across ...

“NextUp” is a weekly NextHealth PHL feature that highlights the local leaders, organizations and research shaping the Greater Philadelphia region’s life sciences ecosystem. Email qmuse@phillymag.com ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The company is seeking to raise additional funding ...

KING OF PRUSSIA, PA--(Marketwired - February 08, 2017) - Genomind, a personalized medicine company advancing mental healthcare through genetic testing, has completed an $11 million financing with its ...

GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the ...

KING OF PRUSSIA, PA--(Marketwired - December 10, 2015) - The largest audience to date will soon learn how personalized medicine for brain health is making a difference for patients. "Innovations," an ...